Skip to main content
Pharmadrug Inc. logo

Pharmadrug Inc. — Investor Relations & Filings

Ticker · PHRX ISIN · CA71716W2040 LEI · 529900PHQPAWL5ITEB39 CSE Manufacturing
Filings indexed 475 across all filing types
Latest filing 2017-08-25 Regulatory Filings
Country CA Canada
Listing CSE PHRX

About Pharmadrug Inc.

https://pharmadrug.ca/

Pharmadrug Inc. is a specialty pharmaceutical company focused on the research, development, and commercialization of controlled-substances and natural medicines. The company's primary focus areas include the clinical development of reformulated natural-based medicines aimed at treating unmet needs in oncology and infectious diseases. Additionally, Pharmadrug develops synthetic and biosynthetic formulations of existing drugs, specifically addressing opportunities related to the potential third wave of drug policy reform concerning controlled substances.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – French.pdf
Regulatory Filings
2017-08-25 English
52-109FV2 - Certification of interim filings - CEO (F).pdf
Regulatory Filings
2017-05-30 English
Interim MD&A - French.pdf
Regulatory Filings
2017-05-30 English
Interim financial statements/report – French.pdf
Regulatory Filings
2017-05-30 English
Letter from successor auditor.pdf
Regulatory Filings
2017-05-30 English
Notice of meeting - English.pdf
Regulatory Filings
2017-05-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.